ReviewAAPS PharmSciTech2025
Strategies to Overcome Challenges in Formulating Tablets from Dried Plant Extracts: a Comprehensive Review.
Review in AAPS PharmSciTech, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Enhancing the Phenolic Value of Polyphenol-Rich Extra Virgin Olive Oils Through Optimized Water Extraction, Macroporous Resin Recovery and Spray Drying.Molecules (Basel, Switzerland) · 2026Article
- Crude Extract Versus Tablet Formulation ofInsects · 2026Article
- Amorphous solid dispersions as a strategy to enhance the bioavailability and stability of formulations containing plant active ingredients: An integrative review.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Traditional medicinal plant derivatives (such as infusions, decoctions, and extracts) are employed in various therapeutic applications due to their wide chemical diversity and multiple biological effects. However, their therapeutic potential is often limited by challenges in conventional pharmaceutical dosage forms, including poor solubility, stability issues, and difficulties in handling and accurate dosing. To overcome these limitations, drying and tableting emerge as viable alternatives, providing stable, cost-effective, uniform, and scalable dosage forms suitable for large-scale production. Nonetheless, factors such as high hygroscopicity, low flowability, poor compressibility, and reduced bioavailability of the complex dried mixture obtained from plant materials pose challenges for tablet formulation. Given this scenario, this review provides a comprehensive overview of these technological hurdles, and explores strategies to overcome them, including the use of excipients to improve flow, optimization of the drying process, granulation techniques, composite particles, solid dispersions, and liquisolid systems. These strategies have enabled the successful development of various types of tablets, such as immediate-release, orodispersible, mucoadhesive, chewable, and extended-release formulations. Finally, this work highlights current advances and practical applications, offering insights into future innovations in the formulation of tablets containing dried plant extracts, including approaches that could facilitate progress toward continuous manufacturing.
Indexed as
Identifiers
41188662What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.